Global Infection Surveillance Solutions Market is valued at approximately USD 500 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 15.00 % over the forecast period 2021-2027. Infection Surveillance is surveillance, in the public health context, is the ongoing, systematic collection, analysis, interpretation and dissemination of data regarding a health-related event for use in public health action to reduce morbidity and mortality and to improve health. Increasing investment in hospital infrastructure, rise in geriatric population has led to the adoption of Infection Surveillance Solutions across the forecast period. For Instance: as per the IBEF, with increasing demand for affordable and quality healthcare, penetration of health insurance is poised to expand in the coming years. In FY21, gross direct premium income underwritten by health insurance companies grew 13.3% YoY to Rs. 58,572.46 crore (US$ 7.9 billion). Also, with the increasing consolidation in the healthcare industry, the adoption & demand for Infection Surveillance Solutions is likely to increase the market growth during the forecast period. However, high cost of deployment for small healthcare organizations impedes the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global Infection Surveillance Solutions market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the growing consolidation among healthcare providers, widespread adoption of healthcare IT solutions. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as rising disposable income, rising population and improving healthcare infrastructure would create lucrative growth prospects for the Infection Surveillance Solutions market across Asia-Pacific region.

Major market players included in this report are:
RL Datix (UK)
Becton, Dickinson and Company (US)
Premier International, Inc. (US)
Wolters Kluwer N.V. (Netherlands)
Cerner Corporation (US)
Baxter International Inc. (US)
GOJO Industries, Inc. (US)
Sunquest (US)
Deb Group Ltd. (UK)
BioVigil Healthcare Systems (US)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Service:
Software
Services
By End Use:
Hospitals
Long-Term Care Facilities
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Infection Surveillance Solutions Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

RL Datix (UK)
Becton, Dickinson and Company (US)
Premier International, Inc. (US)
Wolters Kluwer N.V. (Netherlands)
Cerner Corporation (US)
Baxter International Inc. (US)
GOJO Industries, Inc. (US)
Sunquest (US)
Deb Group Ltd. (UK)
BioVigil Healthcare Systems (US)